Klinische Studien in Greifswald

In Greifswald (Mecklenburg-Vorpommern) rekrutieren 76 klinische Studien an 76 Standorten.

StudiePhaseStatus
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic MiPhase IIIrekrutiert
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic MPhase IIIrekrutiert
A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world Settrekrutiert
A Comparison of Fisetin Kinetics in Young and Old Adultsohne Phasenangaberekrutiert
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head Phase IIIrekrutiert
A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor frekrutiert
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in PrevPhase IIIrekrutiert
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line TreatPhase IIIrekrutiert
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD EvenPhase IIIrekrutiert
A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated rekrutiert
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With PlatinPhase IIrekrutiert
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPPhase I / Phase IIrekrutiert
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary TractPhase IIIrekrutiert
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic MigraiPhase IIrekrutiert
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory DemyePhase IIIrekrutiert
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With MoPhase IIIrekrutiert
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple ScPhase IIIrekrutiert
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With SepPhase IIrekrutiert
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary ArterialPhase IIrekrutiert
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in ParticipantsPhase I / Phase IIrekrutiert
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in AduPhase IIIrekrutiert
Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-CellPhase IIIrekrutiert
Acupuncture Mechanism in Relief of Gag Reflexohne Phasenangaberekrutiert
Acupuncture for Pain Control After Ambulatory Knee Arthroscopyohne Phasenangaberekrutiert
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic LeukaPhase II / Phase IIIrekrutiert
An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psorrekrutiert
Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancerohne Phasenangaberekrutiert
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated LipoprPhase IIIrekrutiert
Autophagy-Enhancers to Reduce Sleep Disturbancesohne Phasenangaberekrutiert
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental DisorderPhase IIIrekrutiert
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by MaintenaPhase IIIrekrutiert
Cognitive Training and Brain Stimulation in Women With Post-chemotherapy Cognitive Impairmentohne Phasenangaberekrutiert
Colorectal Resections in Patients With Retroperitoneal Sarcomarekrutiert
Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell LymPhase IIrekrutiert
Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracrekrutiert
Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMIohne Phasenangaberekrutiert
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With EmpaglPhase IIIrekrutiert
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living WithPhase IIIrekrutiert
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do NPhase IIrekrutiert
Efficacy of the Proactive Automatized Lifestyle Interventionohne Phasenangaberekrutiert
Endometrial Cancer Lymphadenectomy Trialohne Phasenangaberekrutiert
European Disease Registry on Retinopathy of Prematurity (ROP)rekrutiert
Eye Diseases "Treated" With Interoperable Medical Informaticsrekrutiert
GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological rekrutiert
GISAR German Interdisciplinary Sarcoma Registryrekrutiert
GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Trekrutiert
German Dementia Registryrekrutiert
German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm)rekrutiert
Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementatrekrutiert
IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid LeukePhase IIIrekrutiert
INNODIA Family & Friends Early-Stage T1D Detection Protocolrekrutiert
ITP Registry and Accompanying Biospecimen Collectionrekrutiert
Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed MultiPhase IIIrekrutiert
Improved Management of Patients With Recent-Onset Stable Chest Painohne Phasenangaberekrutiert
Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH GPhase IVrekrutiert
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic LymPhase IIIrekrutiert
International HIT-MED Registry (I-HIT-MED)rekrutiert
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDHPhase IIIrekrutiert
Master Framework For Relapse or Refractory Acute Myeloid Leukemiarekrutiert
NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrrekrutiert
NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-rekrutiert
Nivolumab in Children and Adults With Nasopharyngeal CarcinomaPhase IIrekrutiert
Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With NewPhase IIIrekrutiert
Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantationohne Phasenangaberekrutiert
Pulmonary Hemodynamics During Exercise - Research Networkrekrutiert
Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, BlinPhase IIrekrutiert
Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer rekrutiert
Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acrekrutiert
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranPhase IIIrekrutiert
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Accessrekrutiert
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)Phase IIrekrutiert
The Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disordohne Phasenangaberekrutiert
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALPhase IIIrekrutiert
Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic TherapPhase IVrekrutiert
Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune EncephaliPhase IIrekrutiert
Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With RelaPhase I / Phase IIrekrutiert

Wir fragen für Sie nach

Drei Fragen, dann fragen wir bei den Prüfzentren in Ihrer Nähe nach, ob eine passende Studie Teilnehmer aufnimmt. Kostenlos und unverbindlich.

Kostenlos und unverbindlich. Wir beraten nicht und empfehlen keine Studie.

Diese Seite ersetzt kein ärztliches Gespräch. Ob eine Studie für Sie infrage kommt, entscheidet allein das Prüfzentrum nach einem Aufklärungsgespräch und einer Eignungsprüfung. Wir bewerten keine Studie, empfehlen keine Behandlung und stehen in keinem Verhältnis zu den Sponsoren.

Orte in der Nähe

Datenstand: 2026-08-12. Quelle: ClinicalTrials.gov, U.S. National Library of Medicine — gemeinfrei. Der Stand ist der des Abrufs; Studien öffnen und schließen laufend.